141 related articles for article (PubMed ID: 16199150)
21. [Interstitial lung disease in a patient given gemcitabine].
Hammerer V; Schmitz N; Pauli G; Quoix E
Rev Pneumol Clin; 2002 Feb; 58(1):23-6. PubMed ID: 11981501
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary gemcitabine delivery for treating lung cancer: pharmacokinetics and acute lung injury aspects in animals.
Min R; Li T; Du J; Zhang Y; Guo J; Lu WL
Can J Physiol Pharmacol; 2008 May; 86(5):288-98. PubMed ID: 18432290
[TBL] [Abstract][Full Text] [Related]
23. Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I study.
Akrivakis K; Schmid P; Flath B; Schweigert M; Sezer O; Mergenthaler HG; Possinger K
Anticancer Drugs; 1999 Jul; 10(6):525-31. PubMed ID: 10885899
[TBL] [Abstract][Full Text] [Related]
24. BOOP as a rare complication of gemcitabine therapy.
Kawsar HI; Spiro TP; Cocco A; Daw HA
BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689600
[TBL] [Abstract][Full Text] [Related]
25. Delayed anemia and thrombocytopenia after treatment with gemcitabine.
Malayeri R; Krajnik G; Ohler L; Pirker R
J Natl Cancer Inst; 1997 Aug; 89(15):1164. PubMed ID: 9262256
[No Abstract] [Full Text] [Related]
26. Gemcitabine-related pulmonary toxicity.
Joerger M; Gunz A; Speich R; Pestalozzi BC
Swiss Med Wkly; 2002 Jan; 132(1-2):17-20. PubMed ID: 11901447
[TBL] [Abstract][Full Text] [Related]
27. Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project.
Belknap SM; Kuzel TM; Yarnold PR; Slimack N; Lyons EA; Raisch DW; Bennett CL
Cancer; 2006 May; 106(9):2051-7. PubMed ID: 16568459
[TBL] [Abstract][Full Text] [Related]
28. Gemcitabine toxicity.
Marruchella A; Tondini M
Chest; 1999 Nov; 116(5):1491. PubMed ID: 10559502
[No Abstract] [Full Text] [Related]
29. Gemcitabine Induced Cutaneous Collagenous Vasculopathy in a Breast Cancer Patient.
Leone JP
Breast J; 2016 Sep; 22(5):580. PubMed ID: 27346284
[No Abstract] [Full Text] [Related]
30. Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patients.
Locker GJ; Wenzel C; Schmidinger M; Gnant MF; Marosi C; Jakesz R; Zielinski CC; Steger GG
Anticancer Drugs; 2001 Mar; 12(3):209-12. PubMed ID: 11290868
[TBL] [Abstract][Full Text] [Related]
31. Radiation myositis: the possible role of gemcitabine.
Ganem G; Solal-Celigny P; Joffroy A; Tassy D; Delpon A; Dupuis O
Ann Oncol; 2000 Dec; 11(12):1615-6. PubMed ID: 11205473
[No Abstract] [Full Text] [Related]
32. A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
Catimel G; Vermorken JB; Clavel M; de Mulder P; Judson I; Sessa C; Piccart M; Bruntsch U; Verweij J; Wanders J
Ann Oncol; 1994 Jul; 5(6):543-7. PubMed ID: 7918127
[TBL] [Abstract][Full Text] [Related]
33. Vasculitis due to gemcitabine.
Voorburg AM; van Beek FT; Slee PH; Seldenrijk CA; Schramel FM
Lung Cancer; 2002 May; 36(2):203-5. PubMed ID: 11955656
[TBL] [Abstract][Full Text] [Related]
34. [Gemcitabine-induced tumor lysis syndrome caused by recurrent breast cancer in a patient without hemodialysis].
Kawaguchi Ushio A; Hattori M; Kohno N; Kaise H; Iwata H
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1529-32. PubMed ID: 24231708
[TBL] [Abstract][Full Text] [Related]
35. Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy.
Zhang L; Zhang Y; Huang PY; Xu F; Peng PJ; Guan ZZ
Cancer Chemother Pharmacol; 2008 Jan; 61(1):33-8. PubMed ID: 17909810
[TBL] [Abstract][Full Text] [Related]
36. [ASCO Annual Meeting 2004, New Orleans. Gemcitabine in metastatic breast carcinoma].
Longo F; Mansueto G
Tumori; 2004; 90(5):1-8. PubMed ID: 15656346
[No Abstract] [Full Text] [Related]
37. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.
Anderson H; Lund B; Bach F; Thatcher N; Walling J; Hansen HH
J Clin Oncol; 1994 Sep; 12(9):1821-6. PubMed ID: 8083706
[TBL] [Abstract][Full Text] [Related]
38. Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.
Lee HW; Chung MJ; Kang H; Choi H; Choi YJ; Lee KJ; Lee SW; Han SH; Kim JS; Song SY
Gut Liver; 2014 Jan; 8(1):109-12. PubMed ID: 24516709
[TBL] [Abstract][Full Text] [Related]
39. Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine.
Burstein HJ
J Clin Oncol; 2000 Feb; 18(3):693-4. PubMed ID: 10653885
[No Abstract] [Full Text] [Related]
40. Gemcitabine-Induced Retinopathy.
Jhaj G; Jhaj R; Shrier EM
Retina; 2017 Nov; 37(11):e130-e131. PubMed ID: 28961673
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
